drugset / Trial / NCT00497913

Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis

NCT00497913

Phase 3 Completed 52 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a single injection of Dysport with a new protocol at forearm is effective in the management of chronic lateral epicondylitis.

Timeline

Start
2007-08
Primary completion
2008-03
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 60 iu Other

Indications